trial · primary record
Cytarabine
High Risk Myelodysplastic Syndrome
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 116 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Overall response rate (ORR) |
| Registry ID | NCT03214562 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:51.147Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03214562
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cytarabine · approval
- Cytarabine · compound